GMED Globus Medical Inc.

$-0.91 (-1.57%)

GMED Stock Analysis Overview

What this means: Globus Medical Inc. (GMED) gets an Overall Rank of 65, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. GMED's 65 means that it ranks higher than 65% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Globus Medical Inc. (GMED) Analyst Forecast

Next 12 months ➝Current Price$56.9152-week High$60.1552-week Low$33.41MEAN$54.92-3.50%HIGH$67.00+17.73%LOW$46.00-19.17%
  • Last Price$56.91
  • Previous Close$57.82
  • Change $-0.91
  • Open$57.81
  • Volume994,973
  • Avg. Volume (100-day)1,185,105
  • Market Capitalization$6B
  • Days Range $56.24 - $57.98
  • 52-week Range $33.41 - $60.15
  • Dividend Yield
  • Ex. Dividend Date
  • P-E34.9
  • EPS1.45
  • Earnings Date11/03/2020
  • SectorHealthcare
  • IndustryMedical Devices
  • Avg. Analyst Rec.
  • Beta1.6
  • PEG Ratio4.55
Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.